Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)

China flag China · Delayed Price · Currency is CNY
13.12
+0.50 (3.96%)
Mar 10, 2026, 2:05 PM CST
-0.98%
Market Cap 10.41B
Revenue (ttm) 2.75B
Net Income (ttm) 166.07M
Shares Out 824.60M
EPS (ttm) 0.20
PE Ratio 62.69
Forward PE 32.88
Dividend 0.06 (0.47%)
Ex-Dividend Date n/a
Volume 15,609,295
Average Volume 8,126,041
Open 12.26
Previous Close 12.62
Day's Range 12.26 - 13.48
52-Week Range 12.05 - 18.68
Beta 0.08
RSI 33.73
Earnings Date Mar 26, 2026

About SHE:002675

Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas. It offers heparin, chondroitin sulphate sodium and calcium, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C. The company also provides nadroparin calcium, hydrocortisone sodium succinate, chorionic gonadotrophin, and menotropins for... [Read more]

Sector Healthcare
Founded 1998
Employees 2,469
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002675
Full Company Profile

Financial Performance

In 2024, SHE:002675's revenue was 2.87 billion, a decrease of -12.42% compared to the previous year's 3.28 billion. Earnings were 183.83 million, a decrease of -12.35%.

Financial Statements

News

There is no news available yet.